Nautilus Biotechnology (NAUT) Scheduled to Post Quarterly Earnings on Tuesday

Nautilus Biotechnology (NASDAQ:NAUT) will be announcing its earnings results before the market opens on Tuesday, July 30th. Analysts expect the company to announce earnings of ($0.16) per share for the quarter. Parties that wish to listen to the company’s conference call can do so using this link.

Nautilus Biotechnology (NASDAQ:NAUT) last posted its earnings results on Tuesday, April 30th. The company reported ($0.15) EPS for the quarter, topping analysts’ consensus estimates of ($0.16) by $0.01. On average, analysts expect Nautilus Biotechnology to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Nautilus Biotechnology Trading Up 1.4 %

NAUT opened at $2.92 on Monday. Nautilus Biotechnology has a twelve month low of $2.19 and a twelve month high of $4.00. The firm has a market cap of $365.76 million, a price-to-earnings ratio of -5.31 and a beta of 1.20. The company has a fifty day simple moving average of $2.56 and a 200 day simple moving average of $2.68.

Analysts Set New Price Targets

NAUT has been the topic of a number of analyst reports. Guggenheim initiated coverage on Nautilus Biotechnology in a research report on Thursday, June 27th. They set a “buy” rating and a $6.00 target price on the stock. Jefferies Financial Group assumed coverage on Nautilus Biotechnology in a research report on Monday, June 3rd. They issued a “hold” rating and a $3.00 target price on the stock.

About Nautilus Biotechnology

Nautilus Biotechnology, Inc, a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis.